8,314 results found

The list contains only national banks, federal savings associations, and insured federal branches of foreign banks that have received ratings.

On Tuesday, Oct. 24, , the U.S. Senate voted 51-50 to strike down a rule issued by the CFPB that prevented banks, educational institutions and other businesses from including arbitration clauses...

In a settlement with the US DOJ, Kindred Healthcare, Inc., a skilled nursing and long-term care company, has agreed to pay the federal government more than $125 million for alleged False Claims Act violations.

The case was brought as part of the Medicare Fraud Strike Force, which operates in nine cities across the country, and has charged nearly 2,000 defendants who have collectively billed more than $6 billion.

Most of the hundreds of pages comprising the CARES Act, signed into law on March 27, 2020, concern measures for directly counteracting COVID-19 and assisting those dealing with economic consequences of the pandemic.

CMS has released the final version of a broad-based proposed rule update that will take effect November 28, 2016.

Still, the real-world evidence (RWE) gained about these devices while marketed under the EUA need not be lost with the passing of the pandemic.

Were it not for these EUAs, these manufacturers would be unable to market their devices, as their FDA applications would still be pending.

Since taking office, the Trump Administration has taken steps to reshape the United States' federal funding infrastructure. One such action relates to the National Institutes of Health's ("NIH") rate change.

Under federal tied-house prohibitions, suppliers and wholesalers of alcohol are not allowed to provide money, supplies, services, or things of value to retailers, unless an exception is permitted.

Recently, FDA announced issued an alert warning consumers that a brand of ingestible chocolate bars, cones, and gummies called Diamon Shruumz has been linked to a variety of severe heath symptoms...

The FCA creates liability for persons or entities found to have knowingly submitted false claims to the government or having caused others to do so.

A new OIG CMP rule effective January 6, 2017 clarifies the liability guidelines for EMTALA violations.

Among the key aspects in the development of a biosimilar product for the U.S. market is taking advantage of formal meetings with the FDA to gain insight on moving a clinical development program for a proposed biosimilar product forward.

On August 31, 2011, the U.S. Food and Drug Administration ("FDA") issued a draft guidance for sponsors of new drug applications ("NDAs") and abbreviated new drug applications ("ANDAs") providing criteria for evaluating and labeling of tablets that have been scored.

The U.S. Food and Drug Administration has announced the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot, through which FDA...

On September 6, 2018, the FDA launched an alternate to the Traditional 510(k) for submitting a Premarket Notification (510(k)).